Go to the content. | Move to the navigation | Go to the site search | Go to the menu | Contacts | Accessibility

| Create Account

Padalino, Massimo (2008) Surgery for congenital heart disease in the adult age. [Ph.D. thesis]

Full text disponibile come:

[img]
Preview
Documento PDF
1502Kb

Abstract (english)

Despite congenital heart malformations are currently treated in infancy and childhood, a great number of patients still need surgical treatment in adult age. For this reason, we have embarked on a multicentric study involving 7 major italian centers (Padova, Milano S.Donato, Milano Niguarda, Bergamo, Bologna, Massa, Napoli), so as to evaluate the impact of cardiac surgery in adults with congenital heart disease in our country and survival determinants. In addition, clinical late morbidity was analyzed in order to to evaluate correlated pre-operative and operative risk factors.
Methods
We collected data of 856 patients who underwent 1179 procedures from January,1st 2000 to December 31st 2004. Patients were divided into three groups: Group I- Palliation (3.1%): any operation performed to improve patientâ's clinical status without restoring normal anatomy or physiology. Bidirectional cavopulmonary anastomosis and pulmonary artery banding were the most frequent procedures.
Group II- Repair (69.7%): first operation performed in the patient, to achieve an anatomic or physiologic repair by separation of the pulmonary from systemic circulation (including also Fontan-types, and 1 and ’½ ventricle repairs). Most frequent procedures were: atrial septal defect closure (35.8%), partial anomalous pulmonary venous connection repair (7.2%), ventricular septal defect closure (5.3%).
Group III- Reoperation (27.4%): all procedures performed after repair either anatomic or physiologic. The most frequent procedures were conduit replacement (9.8%), aortic (8.6%) or pulmonary valve replacement (7.7%) .
Results
Preoperatively 34.6% of patients were in NYHA class I, 48.4% in class II, 14.2% in class III and 2.8% in class IV. Sinus rhythm was present in 83%.
There were 1179 procedure performed in 856 patients (1.37 procedure/patient), with a hospital mortality of 3.1%. Overall mean intensive care unit stay was 2.3 days (range:1-102 days). Major complications were reported in 247 pts (28.8%), with postoperative arrhythmias being the most frequent (26%).
At mean follow-up of 22 months (range 1 month- 5.5 years), 86% of data were available. Late death occurred in 5 patients (0.5%). Patients were in NYHA class I in 79.3 % , II in 17.6%, III in 2.9%, and only one patient in class IV (0.11%). Ability index was class I in 82%, class II in 13.7% and class III in 2.3%. Overall survival estimates is 82.6% , 99% and 91.8% at 5 years for groups I, II, III respectively. Freedom from adverse events at 5 years is 91% for acyanotic vs 63.9 % for preoperative cyanotic patients (p < 0.0001). Multivariate Cox analysis identifies among the most powerful incremental risk factors for survival preoperative NYHA class IV in cyanotic patients (Hazard Ratio-HR- 8.6, p value 0.001), preoperative NYHA class III (HR 2.7, p value 0.023), and reoperation (HR 2.3, p value 0.029). In addition, multivariate Cox analysis for postoperative morbidity expressed as NYHA class greater than 1, identifies among the most powerful incremental risk factors the length of ICU stay (HR 1.037, CI=1.002-1.072, p=0.036), number of operations (HR 1,445 CI=1,1213-1,721, p<0.001), cyanosis (HR 1,555, CI1,035-2,335, p=0,034), alteration of cardiac rhythm before surgery (HR 1,124, CI=1,040-1,215, p=0,03), pre-operative NYHA class>1 (Hazard Ratio 1,573, CI=0,954-2,593, p=0.076), age > 40y (HR 1,466, CI1,014-2,119, p=0.042).
Conclusions
Surgery for congenital heart disease in adult age is a safe and a low risk treatment. However patients with preoperative cyanosis show a higher incidence of late non-fatal complications. In addition, better preoperative clinical conditions are correlated with better late clinical outcomes, thus early repair (before cardiac and non cardiac organ deterioration occurs) is advocated.


Statistiche Download - Aggiungi a RefWorks
EPrint type:Ph.D. thesis
Tutor:Stellin, Giovanni
Ph.D. course:Ciclo 19 > Corsi per il 19simo ciclo > SCIENZE CARDIOVASCOLARI
Data di deposito della tesi:29 January 2008
Anno di Pubblicazione:29 January 2008
Key Words:Congenital heart disease, cardiac surgery, adult age
Settori scientifico-disciplinari MIUR:Area 06 - Scienze mediche > MED/23 Chirurgia cardiaca
Struttura di riferimento:Dipartimenti > Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari
Codice ID:601
Depositato il:27 Oct 2008
Simple Metadata
Full Metadata
EndNote Format

Bibliografia

I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

1. European Cardio-Thoracic Surgery Association Congenital Database, http://www.eactscongenitaldb.org Vai! Cerca con Google

2. MacMahon B, Mckeown T, Record RG. The incidence and life expectation of children with heart disease. Br Heart J 1953; 15:121. Cerca con Google

3. Moller JH, Taubert KA, Allen HD, Clark EB, Lauer RM. Cardiovascular health and disease in children: current status. A Special Writing Group from the Task Force on Children and Youth, American Heart Association. Circulation. 1994 Feb;89(2):923-30. Cerca con Google

4. Webb GD. Care of adults with congenital heart disease. A challenge for the new millennium. Thorac Cardiovasc Surg 2001; 49:30-34. Cerca con Google

5. Somerville J. Management of adult with congenital heart disease. An emerging increasing problem. Ann Rev Med 1997; 48:283-293. Cerca con Google

6. Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001;37:1170-5. Cerca con Google

7. Williams WG, Webb GD. The emerging population with congenital heart disease. Pediatr Card Surg Annu Semin Thorac Cardiovasc Surg 2000; 3:227-233. Cerca con Google

8. Wren C, O'Sullivan JJ. Survival with congenital heart disease and need for follow up in adult life. Heart 2001; 85: 438-443. Cerca con Google

9. Chessa M, Cullen S, Deanfield J, Frigiola A, Negura DG, Butera G, Giamberti A, Bossone E, Carminati M. The care of adult patients with congenital heart defects: a new challenge. Ital Heart J 2004; 5:178-182. Cerca con Google

10. British Cardiac Society. Current needs and provision of service for adolescents and adults in the United Kingdom. 2002. Cerca con Google

11. Warnes CA. The adult with congenital heart disease. Born to be bad? JACC 2005; 46: 1-8. Cerca con Google

12. Daliento L, Mazzotti E, Mongillo E, Rotundo M, Dalla Volta S. Life expectancy and quality of life in adult patients with congenital heart disease. Ital Heart J 2002; 339-347. Cerca con Google

13. Cetta F, Warnes CA. Adults with congenital heart disease: patient knowledge of endocarditis prophilaxis. Mayo Clin Proc 1995; 70:50-4. Cerca con Google

14. Connelly MS, Webb GD, Somerville J, Warnes CA, Perloff JK, Liberthson RR, Puga FJ, Collins-Nakai RL, Williams WG, Mercier LA, Huckell VF, Finley JP, McKay R.Canadian Consensus Conference on Congenital Heart Defects in the Adult 1996.Can J Cardiol. 1998;14:533-97 Cerca con Google

15. Therrien J, Gatzoulis M, Graham T, Bink-Boelkens M, Connelly M, Niwa K, Mulder B, Pyeritz R, Perloff J, Somerville J, Webb GD. Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the Management of Adults with Congenital Heart Disease—Part II. Can J Cardiol. 2001;17:1029-50. Cerca con Google

16. Deanfield J, Thaulow E, Warnes C, Webb G, Kolbel F, Hoffman A, Sorenson K, Kaemmerer H, Thilen U, Bink Boelkens M, Iserin L, Daliento L, Silove E, Redington A, Vohue P. Management of Grown up congenital heart disease. The task force on the management of grown up congenital heart disease of the European society of cardiology. Eur Heart J 2003; 24:1035-1084. Cerca con Google

17. Webb GD, Williams RG, et al.32nd Bethesda Conference: Care of the adults with congenital heart disease. Am Coll Cardiol 2001; 37:1161-1198. Cerca con Google

18. Viner R. Transition from pediatric to adult care. Bridging the gaps or passing the buck? Arch Dis Child 1999; 81: 271-275. Cerca con Google

19. Foster E, Graham TP, Driscoll DJ, Reid GJ, Reiss JG, Russel IA, Sermer M, Siu SC, Uzark K, Williams RG, Webb GD. Task force 2: special health care needs of adult with congenital heart disease. J Am Coll Cardiol 2001;37:1176-1183. Cerca con Google

20. Stark J. Glenn Lecture. How to choose a cardiac surgeon. Circulation 1996; 94 (Suppl 9): II1-4. Cerca con Google

21. Gatzoulis MA, Webb GD. Adults with congenital heart disease: a growing population. Section one, Chapter 1, in: Gatzoulis MA, Webb GD, Daubeney PEF. Diagnosis and Management of Adult Congenital Heart Disease. Churchill Livingstone. 1st Ed 2003. Cerca con Google

22. Child JS, Collins Nakai RL, Alpert JS, Deanfield JE, Harris L, McLaughlin P, Miner PD, Webb GD, Williams RG. Task force 3: workforce description and educational requirements for the care of adults with congenital heart disease. J Am Coll Cardiol 2001; 37: 1183-1187. Cerca con Google

23. Studio per la qualità  nel trattamento delle cardiopatie in età  pediatrica e nelle cardiopatie congenite nell'adulto. Progetto Baby Heart. www.sicch.it Vai! Cerca con Google

24. Di Salvo G, Pacileo G, Caso P, Verrengia M, Rea A, Santoro G, Giovanna Russo M, Calabro R. Strain rate imaging is a superior method for the assessment of regional myocardial function compared with Doppler tissue imaging: a study on patients with transcatheter device closure of atrial septal defect.J Am Soc Echocardiogr. 2005;18: 398-400. Cerca con Google

25. Nienaber CA, Rehders TC, Fratz S. Detection and assessment of congenital heart disease with magnetic resonance imaging techniques. J Cardiovasc Magn Reson 1999; 1:169-184. Cerca con Google

26. Moon JC, Mc Kenna WJ, McCrohon JA, Elliot PM, Smith PC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomiopathy with gadolinium cardovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-1567. Cerca con Google

27. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ. The histologic basis of late gadolinium enhancement cardiovascula magnetic resonance in hypertrofic cardiomiopathy. J Am Coll Cardiol 2004; 43:2260-2264. Cerca con Google

28. McCrohon JA, Moon JC, Prasad SK, Mc Kenna WJ, Lorenz CH, Coats AJ, Pennell DJ. Differentiation of heart failure related to dilated cardiomiopathy and coronary artery disease using gadolinium enhanced cardiovascula magnetic resonance. Circulation 2003; 108: 54-59. Dowdle SC, Human DG, Mann MD. Cerca con Google

29. Pulmonary ventilation and perfusion abnormalities and ventilation perfusion imbalance in children with pulmonary atresia or extreme tetralogy of Fallot. J Nucl Med. 1990; 31:1276-9. Cerca con Google

30. Chiou CW, Chen SA, Chang CE, et al. Radiofrequency catheter ablation of paroxysmal supraventricular tachycardia in patients with congenital heart disease. In J Cardiol 1995; 50:143. Cerca con Google

31. Deal BJ, Mavroudis C, Backer CL,et al. New directions in surgical therapy of arrhythmias. Pediatr Cardiol 2000; 21: 576. Cerca con Google

32. Sarkar D, Bull D, Yates R, et al. Comparison of long term outcomes of atrial repair of simple transposition with implications for a late arterial switch strategy. Circulation 1999;100(S 19):II187-192. Cerca con Google

33. Julsrud PR, Weigel TJ, Van son JA, et al. Influence of ventricular morphology on outcome after the Fontan procedure. Am J Cardiol 2000; 86: 19-23. Cerca con Google

34. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmias and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000; 356: 975-981. Cerca con Google

35. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population based prospective evaluation of risk of sudden death after operation for common congenital heart defects. J Am Coll Cardiol 1998; 32: 245-251. Cerca con Google

36. Gatzoulis MA, Till JA, Somerville J, et al. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 1995; 92: 231-237. Cerca con Google

37. Thorne SA, Barnes I, Cullinan P et al. Amiodarone associated thyroid dysfunction: risk factors in adults with congenital heart disease. Circulation 1999; 100: 149-154. Cerca con Google

38. van Hare GF. Radiofrequency ablation of accessory pathways associated with congenital heart disease. Pacing Clin Electrophysiol 1997; 20: 2077-2081 Cerca con Google

39. Triedman JK, Bergau DM, Saul JP, et al. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J AM Coll Cardiol 1997; 30: 1032-1038. Cerca con Google

40. Westermann GR, Van Devanter SH. Surgical management of difficult pacing problems in patients with congenital heart disease. J Card Surg 1987; 2: 351-360. Cerca con Google

41. Yap SC, Roos Hesselink JW, Hoendermis ES, Budts W, Vliegen HW, Mulder BJ, van Dijk AP, Schalij MJ, Drenthen W. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi center study. Eur Heart J 2006; 28: 1854-1861. Cerca con Google

42. Dore A, Santagata P, Dubuc M, Mercier LA. Implantable cardioverter defibrillators in adults with congenital heart disease: a single center experience. Pacing Clin Electrophysiol 2004; 27: 47-51. Cerca con Google

43. Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, Fernandes SM, Beauchesne L, Therrien J, Chetaille P, Gordon E, Vonder Muhll I, Cecchin F. Implantable cardioverter defibrillators in tetralogy of Fallot. Circulation 2008; 117: 363-370. Cerca con Google

44. Findlow D, Doyle E. Congenital heart disease in adults. Br J Anesth 1997; 78: 416. Cerca con Google

45. Rosove MH, Perloff JK, Hockin g WG, et al. Chronic hypoxemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet 1986; 2:313. Cerca con Google

46. Henriksson P, Varendh G, Lundstrom NR. Haemostatic defects in cyanotic congenital heart disease. Brit Heart J 1973; 41:23. Cerca con Google

47. Spear GS. The glomerular lesion of cyanotic congenital heart disease. John Hopkins Med J 1977; 140: 185. Cerca con Google

48. Perloff JK. Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism. Cardiol Clin 1993; 11: 689-699. Cerca con Google

49. Perloff JK, Child JS. Non cardiac surgery. In: Congenital heart disease in adults, 2nd Edn. Perloff JK, editor.Philadelphia Sanders 1998; 291-299 Cerca con Google

50. Eisenmenger V. Die angeborenen defecte der kammerscheidenwand des herzens. Z Klin Med 1897; 32: 1-28. Cerca con Google

51. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. BMJ 1958; ii: 701-709, 755-762. Cerca con Google

52. Daliento L, Somerville J, Presbitero P et al. Eisenmenger sindrome. Factors relating to deterioration and death. Eur Heart J 1998; 19: 1845-1855. Cerca con Google

53. Avila WS, Grinberg M, Snitcowsky R et al. Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome. Eur Heart J 1995; 96: 460-464. Cerca con Google

54. Hosenpud JD, Bennet LE, Keck BM aet al. The registry of the international society for heart and lung transplantation: sixteenth official report-1999. J Heart Lung Transplant 1999; 18: 611-626. Cerca con Google

55. Wei Li. Infective endocarditis. Section one, Chapter 15, in: Gatzoulis MA, Webb GD, Daubeney PEF. Diagnosis and Management of Adult Congenital Heart Disease. Churchill Livingstone. 1st Ed 2003. Cerca con Google

56. ESC Task Force on Infective Endocarditis. Eur Heart J 1999 Cerca con Google

57. American College of Cardiology/American Heart Association Task Force on Practical Guideline. Joint Guidelines for the management of patients with valvular Heart disease:executive summary. Circulation 1998; 98: 1949-1984. Cerca con Google

58. Warnes CA. Congenital heart disease and pregnancy. In: Elkayam U, Gleicher N, Editors. Cardiac problems in pregnancy. New york: John Wiley and asociates, 1988. Cerca con Google

59. Siu SC, Sermer M, Harrison DA et al. Risk and predictors for pregnancy related complications in women with heart disease. Circulation 1997; 96: 2789-2794. Cerca con Google

60. Clarkson PM, Wilson NJ, Neutze JM, et al.Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol 1994; 24: 190-193. Cerca con Google

61. Ammash NM, Connolly HM, Abel MD, Warnes CA. Non cardiac surgery in Eisenmenger syndrome. J Am Coll Cardiol 1999; 33:222-227. Cerca con Google

62. Canobbio MM, Mair DD, van der Velde M et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996; 28: 763-767. Cerca con Google

63. Vitale N, De Feo M, De Santo LS, et al. Dose dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999; 71: 1637-1641. Cerca con Google

64. Sader L, McCowan L, White H et al. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. Br J Obstet Gynecol 2000; 107: 245-253. Cerca con Google

65. Presbitero P, Somerville J, Stone S, et al. Pregnancy in cyanotic heart disease. Outcome of mother and fetus. Circulation 1994; 89: 2673-2676. Cerca con Google

66. Leonard H, O'Sullivan JJ, Hunter S. Family planning requirements in the adult congenital heart disease clinic. Heart. 1996;76:60-62. Cerca con Google

67. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception. 1994;49(1):56-72. Cerca con Google

68. Siu S, Chitayat D, Webb G. Pregnancy in women with congenital heart defects: what are the risks? Heart 1999; 81: 225-226. Cerca con Google

69. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996; 62: 179-183. Cerca con Google

70. Nora JJ. From generational studies to a multilevel genetic'environmental interaction. J Am Coll Cardiol 1994; 23: 1468-1471. Cerca con Google

71. Fratz S, Kaemmerer H, Oechslin E et al. Emergency Hospital Admission of Adults with Congenital Heart Disease, a Multicentre Study. JACC. 2000;35(S2):503A. Cerca con Google

72. Stellin G, Vida VL, Padalino MA, Rizzoli G. Surgical outcome for congenital heart malformations in the adult age. A multicentric European study. Ped Card Surg Ann Sem Thorac Cardiovasc Surg 2004; 7: 95-101. Cerca con Google

73. Kristeller JL, Roslund BP, Stahl RF. Benefits and risks of aprotinin use during cardiac surgery. Pharmacotherapy. 2008; 28:112-124. Cerca con Google

74. Backer CL, Kelle AM, Stewart RD, Suresh SC, Ali FN, Cohn RA, Seshadri R, Mavroudis C. Aprotinin is safe in pediatric patients undergoing cardiac surgery.J Thorac Cardiovasc Surg. 2007;134:1421-1426. Cerca con Google

75. Naik SK, Knight A, Elliott MJ. A. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion 1991; 6:41-50. Cerca con Google

76. Maehara T, Novak I, Elliott MJ. Perioperative monitoring of total body water by bio-electrical impedance in children undergoing open heart surgery. Eur J Cardiothorac Surg 1991; 5: 258-265. Cerca con Google

77. Naik SK, Balaji S, Elliott MJ. Modified ultrafiltration improves hemodynamics after cardiopulmonary bypass in children. [abstract]. J Am Coll Cardiol 1993;19:37. Cerca con Google

78. Gaynor JW. The effect of modified ultrafiltration on the postoperative course in patients with congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2003;6:128-39. Cerca con Google

79. Perloff JK, Rosove MH, Child JS et al. Adults with cyanotic congenital heart disease: hematologic management. Ann Intern Med 1988;109:406-413. Cerca con Google

80. Dajani AS, Taubert KA, Wilson W et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation. 1997; 96:358-366. Cerca con Google

81. BaumVC, Perloff JK. Anesthetic implications of adults with congenital heart disease. Anesth Analg 1993; 76: 1342-1358. Cerca con Google

82. Warner MA, Lunn RJ, P.W. O'Leary PW, Schroeder DR. Outcomes of noncardiac surgical procedures in children and adults with congenital heart disease. Mayo Perioperative Outcomes Group, Mayo Clin Proc 1998; 73: 728-734. Cerca con Google

83. Lamour JM, Addonizio LJ, Galantowicz ME et al. Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. Circulation. 1999;100(Suppl II):II200-II205. Cerca con Google

84. Carey JA, Hamilton JRL, Hilton CJ et al. Orthotopic cardiac transplantation for the failing fontan circulation. Eur J Cardio-Thorac Surg. 1998;14:7-14. Cerca con Google

85. Pigula FA, Gandhi S, Ritisch J et al. Cardipulmonary transplantation for congenital heart disease in the adult. J Heart Lung Transplant. 2000;19:94 (abstract). Cerca con Google

86. Aaronson K, Schwartz JS, Chen T et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660-2667. Cerca con Google

87. Hosenpud JD, Bennett LE, Keck BM et al. The registry of the international society for heart and lung transplantation: Sixteenth official report - 1999. J Heart Lung Transplant. 1999;18:611—626. Cerca con Google

88. Horner T, Liberthson R, Jellinek MS. Psychosocial profile of adults with complex congenital heart disease. Mayo Clin Proc. 2000;75:31-36. Cerca con Google

89. Van Tongerloo A, De Paepe A. Psychosocial adaptation in adolescence and young adults with Marfan syndrome: An exploratory study. J Med Genet. 1998;35:405-409. Cerca con Google

90. Gersony WM, Hayes CJ, Driscoll DJ et al. Second natural history, study of congenital heart defects: quality oflife of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. 1993;87(Suppl I):I-52-I-65. Cerca con Google

91. Newburger J, Silbert A, Buckley L et al. Cognitive function and age at repair of transposition of the great arteries in children. N Eng J Med. 1984;310:1495-1499. Cerca con Google

92. Miller G, Vogel H. Structural evidence of injury or malformation in the brains of children with congenital heart disease. Semin Pediatr Neurol. 1999;6(1):20-26. Cerca con Google

93. McGrath KA, Truesdell SC. Employability and career counseling for adolescents and adults with congenital heart disease. Nurs Clin North Am. 1994;29:319-330. Cerca con Google

94. Manning J. Insurability and employability of young cardiac patients. Engle M. Paediatric Cardiovascular Disease. 2nd Edn. Philadelphia: Davis; 1981, 117-127. Cerca con Google

95. Celermajer DS, Deanfield JE. Employment and Insurance for Young Adults with Congenital Heart Disease. Br Heart J. 1993;69:539-543. Cerca con Google

96. Kaemmerer H, Tintner H, Konig U et al. Psychosocialproblems of adolescents and adults with congenital heart defects. Z Kardiol. 1994;83(3):194-200. Cerca con Google

97. Opocher F, Varnier M, Sanders SP, Tosoni A, Zaccaria M, Stellin G, Milanesi O. Effects of aerobic exercise training in children after the Fontan operation. Am J Cardiol. 2005; 95: 150-2. Cerca con Google

98. Cullen S, Celermajer DS, Deanfield JE. Exercise in Congenital Heart Disease. Cardiol in the Young. 1991;1:129-135. Cerca con Google

99. Fredriksen PM, Veldtman G, Hechter S et al. Aerobiccapacity in adults with various congenital heart diseases. Am J Cardiol. 2001;87:310-314. Cerca con Google

100. Maron BJ, Isner JM, McKenna W. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. J Am Coll Cardiol. 1994;24:880-885. Cerca con Google

101. Meijboom F, Szatmari A, Deckers JW et al. Cardiacstatus and health-related quality of life in the long term after surgical repair of tetralogy of Fallot in infancy and childhood. J Thorac Cardiovasc Surg. 1995;110:883-891. Cerca con Google

102. Norozi K, Wessel A, Buchhorn R, Alpers V, Arnhold JO, Zoege M, Geyer S. Is the ability index superior to the NYHA classification for assessing heart failure? Comparison of two classification scales in adolescents and adults with operated congenital heart defects. Clin Res Cardiol 2007; 96: 542-7. Cerca con Google

103. Srinathan SK, Bonser RS, Sethia B, Thorne SA, Brawn WJ, Barron DJ. Changing practice of cardiac surgery in adult patients with congenital heart disease. Heart 2004; 91: 207-212. Cerca con Google

104. Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A, Pome G, Bossone E, Frigiola A. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J. 2006 Jan;151(1):228-34. Cerca con Google

105. Murphy JG, Gersh BJ, McGoon MD, et al. Long term outcome after surgical repair of isolated atrial defect. Follow up at 27 to 32 years. N Eng J Med 1990;333:469-73. Cerca con Google

106. Berdat PA, Immer F, Pfammatter JP, Carrel T. Reoperations in adults with congenital heart disease: analysis of outcome. Intern J Cardiol 2004; 93:239-245. Cerca con Google

107. Dore A, Luke Glancy D, Stone S, Menasche VD, Somerville J. Cardiac surgery for Grown Up Congenital heart patients: survey of 307 consecutive operations from 1991 to 1994. Am J Cardiol 1997; 80:906-913. Cerca con Google

108. Isomura T, Hisatomi K, Andoh F, et al. Reoperation following total repair of congenital heart disease. Jpn Circ J, 1991; 55:453-458. Cerca con Google

109. Geissler HJ, Sudkamp M, Nowak J, de Vivie ER. Congenital heart defects in adolescence and adulthood: fatalities and morbidity in primary and reoperation. Z Kardiol 1996; 85: 782-789. Cerca con Google

110. Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD. Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: are we operating too late? J Am Coll Cardiol 2000; 36: 1670-1675. Cerca con Google

111. Diller GP, Dimopoulos K, Okonko D, Li W, Babu Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease. Comparative severity, correlates and prognostic implications. Circulation, 2005;112:828-835. Cerca con Google

112. Castaneda AR, Mayer JE, Jonas RA, Lock JE, Wessel DL, Hickey PR. The neonate with critical congenital heart disease: Repair - A surgical challenge. J Thorac Cardiovasc Surg 1989;98:869-75. Cerca con Google

113. Vida VL, Berggren H, Brawn WJ, Daenen W, Di Carlo D, Di Donato R, Lindberg HL, Corno AF, Fragata J, Elliott MJ, Hraska V, Kiraly L, Lacour-Gayet F, Maruszewski B, Rubay J, Sairanen H, Sarris G, Urban A, Van Doorn C, Ziemer G, Stellin G. Risk of surgery for congenital heart disease in the adult: a multicentered European study.Ann Thorac Surg. 2007 Jan;83(1):161-8. Cerca con Google

114. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. First of two parts. N Engl J Med 2000; 342: 256-263. Cerca con Google

Download statistics

Solo per lo Staff dell Archivio: Modifica questo record